Design, synthesis and in vitro evaluation of a new class of novel cyclooxygenase-2 inhibitors:: 3, 4-diaryl-3-pyrrolin-2-ones

被引：0

作者：

Bai, AP

Guo, ZR

Hu, WH

Shen, F

Cheng, GF

机构：

[1] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China

[2] Beijing Union Med Coll, Beijing 100050, Peoples R China

来源：

CHINESE CHEMICAL LETTERS | 2001年 / 12卷 / 09期

关键词：

cyclooxyenase-2; inhibitor; NSAIDs (non-steroidal anti-inflammatory drugs);

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

design, synthesis and in vivo evaluation of a new class of COX-2 inhibitors 3, 4-diaryl-3-pyrrolin-2-ones are reported.

引用

页码：775 / 778

页数：4

共 6 条

[1] 2,3-diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors [J].

Black, WC ;

Brideau, C ;

Chan, CC ;

Charleson, S ;

Chauret, N ;

Claveau, D ;

Ethier, D ;

Gordon, R ;

Greig, G ;

Guay, J ;

Hughes, G ;

Jolicoeur, P ;

Leblanc, Y ;

Nicoll-Griffith, D ;

Ouimet, N ;

Riendeau, D ;

Visco, D ;

Wang, ZY ;

Xu, L ;

Prasit, P .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) :1274-1281

[2] Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model [J].

Ehrich, EW ;

Dallob, A ;

De Lepeleire, I ;

Van Hecken, A ;

Riendeau, D ;

Yuan, WY ;

Porras, A ;

Wittreich, J ;

Seibold, JR ;

De Schepper, P ;

Mehlisch, DR ;

Gertz, BJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :336-347

[3] 1,2-diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2 [J].

Khanna, IK ;

Weier, RM ;

Yu, Y ;

Collins, PW ;

Miyashiro, JM ;

Koboldt, CM ;

Veenhuizen, AW ;

Currie, JL ;

Seibert, K ;

Isakson, PC .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1619-1633

[4] 1,2-diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents [J].

Khanna, IK ;

Weier, RM ;

Yu, Y ;

Xu, XD ;

Koszyk, FJ ;

Collins, PW ;

Koboldt, CM ;

Veenhuizen, AW ;

Perkins, WE ;

Casler, JJ ;

Masferrer, JL ;

Zhang, YY ;

Gregory, SA ;

Seibert, K ;

Isakson, PC .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1634-1647

[5] Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib) [J].

Penning, TD ;

Talley, JJ ;

Bertenshaw, SR ;

Carter, JS ;

Collins, PW ;

Docter, S ;

Graneto, MJ ;

Lee, LF ;

Malecha, JW ;

Miyashiro, JM ;

Rogers, RS ;

Rogier, DJ ;

Yu, SS ;

Anderson, GD ;

Burton, EG ;

Cogburn, JN ;

Gregory, SA ;

Koboldt, CM ;

Perkins, WE ;

Seibert, K ;

Veenhuizen, AW ;

Zhang, YY ;

Isakson, PC .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) :1347-1365

[6] The discovery of rofecoxib, [MK 966, Vioxx®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor [J].

Prasit, P ;

Wang, Z ;

Brideau, C ;

Chan, CC ;

Charleson, S ;

Cromlish, W ;

Ethier, D ;

Evans, JF ;

Ford-Hutchinson, AW ;

Gauthier, JY ;

Gordon, R ;

Guay, J ;

Gresser, M ;

Kargman, S ;

Kennedy, B ;

Leblanc, Y ;

Léger, S ;

Mancini, J ;

O'Neill, GP ;

Ouellet, M ;

Percival, MD ;

Perrier, H ;

Riendeau, D ;

Rodger, I ;

Tagari, P ;

Thérien, M ;

Vickers, P ;

Wong, E ;

Xu, LJ ;

Young, RN ;

Zamboni, R ;

Boyce, S ;

Rupniak, N ;

Forrest, N ;

Visco, D ;

Patrick, D .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) :1773-1778

← 1 →